Firm was notified by the foreign manufacturer that certain lots of Ultra-CRP are prone to prozone (a condition of antibody antigen excess) and do not meet the labeled specifications.
Source facts
Action
By phone on 12/3/03 and by mail on 12/5/03.
Initiated
2003-12-03
Root cause
Other
Terminated
2005-04-20
Distribution
Medical facilities, physicians, diagnostic laboratories, and distributors located nationwide.
Recall number
Z-0296-04
Recall status
Terminated
CDRH record ID
30671
FDA classified
2004-01-06
Recall event number
27874
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.